{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:02:55Z","timestamp":1776834175115,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-114-2314-B-195-014-MY3"],"award-info":[{"award-number":["NSTC-114-2314-B-195-014-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-11342"],"award-info":[{"award-number":["MMH-11342"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"DOI":"10.1007\/s00418-026-02480-y","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:22:20Z","timestamp":1776831740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic overexpression of kallikrein-related peptidase 7 is associated with the progression of thyroid cancer"],"prefix":"10.1007","volume":"164","author":[{"given":"Shun-Yu","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-5096","authenticated-orcid":false,"given":"Shih-Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"1","key":"2480_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrae139","volume":"9","author":"NM Ahmed","year":"2024","unstructured":"Ahmed NM, Eddama MMR, Beatson K, Gurung R, Patel J, Iskandar G, Abdel-Salam A, Al-Omar A, Cohen R, Abdel-Aziz T, Clapp L (2024) Circulating large extracellular vesicles as diagnostic biomarkers of indeterminate thyroid nodules: multi-platform omics analysis. BJS Open 9(1):zrae139. https:\/\/doi.org\/10.1093\/bjsopen\/zrae139","journal-title":"BJS Open"},{"issue":"5","key":"2480_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/thy.2017.0501","volume":"28","author":"R Buj","year":"2018","unstructured":"Buj R, Mallona I, Diez-Villanueva A, Zafon C, Mate JL, Roca M, Puig-Domingo M, Reverter JL, Mauricio D, Peinado MA, Jorda M (2018) Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications. Thyroid 28(5):601\u2013612. https:\/\/doi.org\/10.1089\/thy.2017.0501","journal-title":"Thyroid"},{"issue":"4","key":"2480_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10238-016-0445-y","volume":"17","author":"SP Cheng","year":"2017","unstructured":"Cheng SP, Chen MJ, Chien MN, Lin CH, Lee JJ, Liu CL (2017) Overexpression of teneurin transmembrane protein 1 is a potential marker of disease progression in papillary thyroid carcinoma. Clin Exp Med 17(4):555\u2013564. https:\/\/doi.org\/10.1007\/s10238-016-0445-y","journal-title":"Clin Exp Med"},{"issue":"2","key":"2480_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/path.5503","volume":"252","author":"SP Cheng","year":"2020","unstructured":"Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS, Liu CL (2020) Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. J Pathol 252(2):114\u2013124. https:\/\/doi.org\/10.1002\/path.5503","journal-title":"J Pathol"},{"issue":"4","key":"2480_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/omi.2024.0189","volume":"29","author":"SY Chi","year":"2025","unstructured":"Chi SY, Hsu YC, Cheng SP (2025a) Effect of genetic ancestry on phenotypes and genotypes in papillary thyroid cancer. OMICS 29(4):117\u2013124. https:\/\/doi.org\/10.1089\/omi.2024.0189","journal-title":"OMICS"},{"issue":"1","key":"2480_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00418-025-02357-6","volume":"163","author":"SY Chi","year":"2025","unstructured":"Chi SY, Hsu YC, Tsai CH, Huang SY, Chang SC, Cheng SP (2025b) Identifying CSNK1E as a therapeutic target in thyroid cancer among the core circadian clock genes. Histochem Cell Biol 163(1):30. https:\/\/doi.org\/10.1007\/s00418-025-02357-6","journal-title":"Histochem Cell Biol"},{"issue":"10","key":"2480_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/14728222.2024.2415014","volume":"28","author":"GN Daneva","year":"2024","unstructured":"Daneva GN, Tsiakanikas P, Adamopoulos PG, Scorilas A (2024) Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer. Expert Opin Ther Targets 28(10):875\u2013894. https:\/\/doi.org\/10.1080\/14728222.2024.2415014","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"2480_CR8","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1158\/0008-5472.CAN-09-3415","volume":"70","author":"Y Dong","year":"2010","unstructured":"Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 70(7):2624\u20132633. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3415","journal-title":"Cancer Res"},{"issue":"1","key":"2480_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41379-020-0630-0","volume":"34","author":"J Haase","year":"2021","unstructured":"Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Potschke R, Mensch A, Bell JL, Dralle H, Siebolts U, Wickenhauser C, Lorenz K, Huttelmaier S (2021) IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol 34(1):32\u201341. https:\/\/doi.org\/10.1038\/s41379-020-0630-0","journal-title":"Mod Pathol"},{"issue":"9","key":"2480_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1515\/hsz-2017-0339","volume":"399","author":"M Haddada","year":"2018","unstructured":"Haddada M, Draoui H, Deschamps L, Walker F, Delaunay T, Brattsand M, Magdolen V, Darmoul D (2018) Kallikrein-related peptidase 7 overexpression in melanoma cells modulates cell adhesion leading to a malignant phenotype. Biol Chem 399(9):1099\u20131105. https:\/\/doi.org\/10.1515\/hsz-2017-0339","journal-title":"Biol Chem"},{"issue":"9","key":"2480_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18(9):533\u2013548. https:\/\/doi.org\/10.1038\/s41568-018-0038-z","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2480_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"4","key":"2480_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1210\/clinem\/dgae687","volume":"110","author":"YC Hsu","year":"2025","unstructured":"Hsu YC, Kuo CY, Chien MN, Jhuang JY, Huang SY, Chang SC, Cheng SP (2025) Overexpression of NR1D1 portends disease recurrence in thyroid cancer. J Clin Endocrinol Metab 110(4):991\u20131002. https:\/\/doi.org\/10.1210\/clinem\/dgae687","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2480_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.6890\/IJGE.202407_18(3).0002","volume":"18","author":"OO Keskiner","year":"2024","unstructured":"Keskiner OO, Ozturk Y, Ozer H, Baloglu I, Uysal S, Toker A, Keskin S, Turkmen K (2024) Evaluation of the association of serum sclerostin and carotid intima media thickness with chronic kidney failure and kidney transplantation. Int J Gerontol 18(3):144\u2013149. https:\/\/doi.org\/10.6890\/IJGE.202407_18(3).0002","journal-title":"Int J Gerontol"},{"issue":"4","key":"2480_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3904\/kjim.2010.25.4.399","volume":"25","author":"HS Kim","year":"2010","unstructured":"Kim HS, Kim DH, Kim JY, Jeoung NH, Lee IK, Bong JG, Jung ED (2010) Microarray analysis of papillary thyroid cancers in Korean. Korean J Intern Med 25(4):399\u2013407. https:\/\/doi.org\/10.3904\/kjim.2010.25.4.399","journal-title":"Korean J Intern Med"},{"issue":"1","key":"2480_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1186\/s12885-024-12552-8","volume":"24","author":"S Kind","year":"2024","unstructured":"Kind S, Castillo CP, Schlichter R, Gorbokon N, Lennartz M, Hornsteiner LS, Dwertmann Rico S, Reiswich V, Viehweger F, Kluth M, Hube-Magg C, Bernreuther C, Buscheck F, Clauditz TS, Fraune C, Hinsch A, Krech T, Lebok P, Steurer S, Burandt E, Minner S, Marx AH, Simon R, Wilczak W, Sauter G, Menz A, Jacobsen F (2024) KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors. BMC Cancer 24(1):794. https:\/\/doi.org\/10.1186\/s12885-024-12552-8","journal-title":"BMC Cancer"},{"key":"2480_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.biochi.2015.09.002","volume":"122","author":"T Kryza","year":"2016","unstructured":"Kryza T, Silva ML, Loessner D, Heuze-Vourc\u2019h N, Clements JA (2016) The kallikrein-related peptidase family: dysregulation and functions during cancer progression. Biochimie 122:283\u2013299. https:\/\/doi.org\/10.1016\/j.biochi.2015.09.002","journal-title":"Biochimie"},{"issue":"2","key":"2480_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/ERC-21-0256","volume":"29","author":"CY Kuo","year":"2021","unstructured":"Kuo CY, Chang YC, Chien MN, Jhuang JY, Hsu YC, Huang SY, Cheng SP (2021) SREBP1 promotes invasive phenotypes by upregulating CYR61\/CTGF via the Hippo-YAP pathway. Endocr Relat Cancer 29(2):47\u201358. https:\/\/doi.org\/10.1530\/ERC-21-0256","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"2480_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/hed.27953","volume":"47","author":"CY Kuo","year":"2025","unstructured":"Kuo CY, Hsu YC, Chen MJ, Lin CH, Li YS, Cheng SP (2025) Glucose transporter 1 inhibitors induce autophagy and synergize with lenvatinib in thyroid cancer cells. Head Neck 47(2):615\u2013624. https:\/\/doi.org\/10.1002\/hed.27953","journal-title":"Head Neck"},{"issue":"10","key":"2480_CR20","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","volume":"25","author":"I Landa","year":"2019","unstructured":"Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE (2019) Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies. Clin Cancer Res 25(10):3141\u20133151. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2953","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2480_CR21","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-25-0136","volume":"267","author":"JJ Lee","year":"2025","unstructured":"Lee JJ, Hsu YC, Kuo CY, Huang SY, Chang SC, Cheng SP (2025) A TIMELESS link to dedifferentiation in thyroid cancer. J Endocrinol 267(1):e250136. https:\/\/doi.org\/10.1530\/JOE-25-0136","journal-title":"J Endocrinol"},{"issue":"5","key":"2480_CR22","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.7150\/jca.101555","volume":"16","author":"M Li","year":"2025","unstructured":"Li M, Li ZW, Song JY, Bin Y, Ni T, Xue G, Lin X, Wu JF (2025) KLK7 involvement in thyroid papillary carcinoma cell migration and invasion by EMT via MAPK\/ERK pathways. J Cancer 16(5):1709\u20131725. https:\/\/doi.org\/10.7150\/jca.101555","journal-title":"J Cancer"},{"issue":"12","key":"2480_CR23","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac171","volume":"163","author":"CL Liu","year":"2022","unstructured":"Liu CL, Hsu YC, Kuo CY, Jhuang JY, Li YS, Cheng SP (2022) CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the integrin\/FAK\/AKT pathway. Endocrinology 163(12):bqac171. https:\/\/doi.org\/10.1210\/endocr\/bqac171","journal-title":"Endocrinology"},{"key":"2480_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2019.100019","volume":"6-7","author":"P Nauroy","year":"2019","unstructured":"Nauroy P, Nystrom A (2019) Kallikreins: essential epidermal messengers for regulation of the skin microenvironment during homeostasis, repair and disease. Matrix Biol plus 6\u20137:100019. https:\/\/doi.org\/10.1016\/j.mbplus.2019.100019","journal-title":"Matrix Biol plus"},{"issue":"6","key":"2480_CR25","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1007\/s10528-024-10679-8","volume":"62","author":"T Ni","year":"2024","unstructured":"Ni T, Zhao RH, Wu JF, Li CY, Xue G, Lin X (2024) KLK7, KLK10, and KLK11 in papillary thyroid cancer: bioinformatic analysis and experimental validation. Biochem Genet 62(6):4446\u20134471. https:\/\/doi.org\/10.1007\/s10528-024-10679-8","journal-title":"Biochem Genet"},{"issue":"1","key":"2480_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/CBM-181758","volume":"24","author":"I Reyes","year":"2019","unstructured":"Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A, Moscatello A, Schantz S, Tiwari RK, Geliebter J (2019) Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomark 24(1):71\u201383. https:\/\/doi.org\/10.3233\/CBM-181758","journal-title":"Cancer Biomark"},{"issue":"Suppl 1(Suppl 1","key":"2480_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-16-S1-S7","volume":"16","author":"HJ Schulten","year":"2015","unstructured":"Schulten HJ, Al-Mansouri Z, Baghallab I, Bagatian N, Subhi O, Karim S, Al-Aradati H, Al-Mutawa A, Johary A, Meccawy AA, Al-Ghamdi K, Al-Hamour O, Al-Qahtani MH, Al-Maghrabi J (2015) Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid. BMC Genomics 16(Suppl 1(Suppl 1)):S7. https:\/\/doi.org\/10.1186\/1471-2164-16-S1-S7","journal-title":"BMC Genomics"},{"issue":"4","key":"2480_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41568-021-00436-z","volume":"22","author":"S Srinivasan","year":"2022","unstructured":"Srinivasan S, Kryza T, Batra J, Clements J (2022) Remodelling of the tumour microenvironment by the kallikrein-related peptidases. Nat Rev Cancer 22(4):223\u2013238. https:\/\/doi.org\/10.1038\/s41568-021-00436-z","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2480_CR29","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nmeth.3995","volume":"13","author":"M Uhlen","year":"2016","unstructured":"Uhlen M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E, Rimm DL, Rodriguez H, Hiltke T, Snyder M, Yamamoto T (2016) A proposal for validation of antibodies. Nat Methods 13(10):823\u2013827. https:\/\/doi.org\/10.1038\/nmeth.3995","journal-title":"Nat Methods"},{"issue":"10","key":"2480_CR30","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00432-021-03706-3","volume":"147","author":"Y Wang","year":"2021","unstructured":"Wang Y, McKelvey BA, Liu Z, Rooper L, Cope LM, Zeiger MA, Umbricht CB (2021) Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens. J Cancer Res Clin Oncol 147(10):2983\u20132991. https:\/\/doi.org\/10.1007\/s00432-021-03706-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"15","key":"2480_CR31","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.2174\/0929867328666210915104537","volume":"29","author":"F Xiang","year":"2022","unstructured":"Xiang F, Wang Y, Cao C, Li Q, Deng H, Zheng J, Liu X, Tan X (2022) The role of kallikrein 7 in tumorigenesis. Curr Med Chem 29(15):2617\u20132631. https:\/\/doi.org\/10.2174\/0929867328666210915104537","journal-title":"Curr Med Chem"},{"issue":"29","key":"2480_CR32","doi-asserted-by":"publisher","first-page":"17762","DOI":"10.1074\/jbc.M115.643551","volume":"290","author":"Y Yu","year":"2015","unstructured":"Yu Y, Prassas I, Dimitromanolakis A, Diamandis EP (2015) Novel biological substrates of human kallikrein 7 identified through degradomics. J Biol Chem 290(29):17762\u201317775. https:\/\/doi.org\/10.1074\/jbc.M115.643551","journal-title":"J Biol Chem"},{"issue":"10","key":"2480_CR33","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.1002\/jcp.26425","volume":"233","author":"H Zhang","year":"2018","unstructured":"Zhang H, Cai Y, Zheng L, Zhang Z, Lin X, Jiang N (2018) Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p\/KLK7 expression. J Cell Physiol 233(10):6638\u20136648. https:\/\/doi.org\/10.1002\/jcp.26425","journal-title":"J Cell Physiol"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-026-02480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00418-026-02480-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-026-02480-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:22:22Z","timestamp":1776831742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00418-026-02480-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s00418-026-02480-y","relation":{},"ISSN":["1432-119X"],"issn-type":[{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"26"}}